Mesocarb (brand names Sidnocarb, Sydnocarb) is a drug that is currently being developed for Parkinson's disease. The drug was originally developed in the USSR in the 1970s for a variety of indications including asthenia, apathy, adynamia and some clinical aspects of depression and schizophrenia. It has been found to act as a selective dopamine reuptake inhibit and is less potent and slower-acting but longer-lasting than dextroamphetamine.
Mesocarb: Mesocarb (brand names Sidnocarb... - Cure Parkinson's
Mesocarb
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Not what you're looking for?
You may also like...
Natural Kaempferol Delays Parkinson’s Symptoms in Fruit Fly Model
delays-parkinsons-symptoms-in-fruit-fly-model/
\\"The natural compound kaempferol — which acts as a...
Fast acting Levodopa?
that somebody had written about making a quick acting levodopa by grinding up a tab of Sinemet or...
You Might Want to Stock Up On NAC (if you use it)
Food and Drug Administration cease its “unlawful retroactive application of the Food, Drug, and...
Do you suffer from iRBD
sleep back without taking medications? I have developed a diet (just food) that can down-regulate...
Has anybody found a way to reduce dyskinesia without Amantadine?
dose at noon.
There are at least a couple drugs being developed that may help with dyskinesia, but...
Related Posts
The Latest in Efforts to Develop a Vaccine against Parkinson’s
New Horizons but a few obstacles that we must conquer. - Can we give CuATSM a try without waiting for the Australian trial completion (5 years from now)
Recording available - Dr. Jonathan Sackner-Bernstein: \"What If I Discovered the Silver Bullet?\"
Neurologic vs physical symptoms of PD
